Description
Brazil is the fifth largest country in the world, after Russia, Canada, China and the United States. The size of the country as made it a focus for IVD companies. This report, The IVD Market in Brazil, provides market estimates and forecasts for the main categories of in vitro diagnostics, and forecasts those markets to 2017. Information was obtained by both primary and secondary sources. Annual reports, trade publications, as well as telephone and email surveys of IVD manufacturers operating in Brazil were utilized to construct market estimates.
Though large international companies are present, the report describes how the Brazilian IVD market offers interesting growth opportunities due to increasing healthcare budgets in the country, along with a higher number of private hospitals and the rising income levels backed by a huge, untapped population bases. Particular opportunities are present in the cities of Sao Paulo, Rio de Janeiro, Belo Horizonte, Porto Alegre, Brasilia, Salvador, Recife, Fortaleza and Curitiba.
This Kalorama Information report provides specific market estimates for the following:
- Brazilian Clinical Chemistry Market
- Brazilian Microbiology Market
- Brazilian Point of Care Market(Glucose, Other POC)
- Brazilian Immunoassay Market (Microbiology Immunoassays, Other Immunoassays)
- Brazilian Cardiac Marker Market
- Brazilian Urinalysis Market
- Brazilian Molecular Test Market in Brazil
- Brazilian Coagulation Testing Market
- Brazilian Histology Market (Traditional, ICH/FISH/ISH)
- Brazilian Hematology Testing Market
- Brazilian Blood Testing Market
- Brazilian Flow Cytometry Market
In addition to market numbers for business planning activities, the report also provides the following useful data:
- Health Insurance Coverage
- Labs in Brazil, (large, small, hospital/commercial)
- Brazil Healthcare Statistics
- Overview of Brazilian Healthcare System
- Analyst Conclusions
- Regional Breakout of Brazilian IVD Market
- Market Share by Companies
- Lab Automation Market Opportunity
The report provides market estimates for a time period ranging from 2012 to 2017. Information was obtained by both primary and secondary sources. Annual reports, trade publications, as well as telephone and email surveys of IVD manufacturers operating in Brazil were utilized to construct market estimates.
The report is collaboration between Kalorama Information and VA Consultora y Asociados. VA Consultora y Asociados is a consultant company founded and directed by Dr. María Victoria Allais, with more than 20 years in the IVD market and its different segments. Internal knowledge and expertise lead to real time intelligence on the diagnostic market including new technologies and forecasting. In-depth qualitative and quantitative research focused on LATAM region and country specific trends. More information is available at: www.vaconsultora.com.ar
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
Overview
World Market Summary
Methodology
CHAPTER TWO: INTRODUCTION
Laboratory Informatics in Flux
Variations of LIS
For the Drug Industry
For Clinical Laboratories
Variety of Functions
Key Functionality
Clinical Laboratories
Drug Discovery Laboratories
Verifying Workflow
Automation and Competitiveness
Integration and Interconnectivity
Integrating the Pharmaceutical Laboratory with Corporate Decision Makers
Enterprise Capability
Clinical Diagnostic Integration
Electronic Medical Records
Point of Care Testing
Benefits and Tradeoffs of LIS
Improving Data Management
Improved Trackability
CHAPTER THREE: TRENDS AND ISSUES
Emerging Trends
No Longer A Side Issue
Data Mobility
Commercial Off the Shelf Systems
Some Customization Needed
Software As A Service
Open Architecture
For the Pharma Lab
For the Clinical Lab
Reducing Costs
Rental Option
Standardization
Significant Laboratory Challenges
Choosing A System
Key Questions from Users
Vendor Challenges and Concerns
Configurability
CHAPTER FOUR: RECENT MARKET DEVELOPMENTS
Accelrys Acquires Aegis, Vialis
Roper Acquires Sunquest
StarLims Acquires Distributors
Cerner Expands with Labotix Acquisition
Accelrys Suite, Partnership
Next-Generation Sequencing
Proof of Concept Service
On-Demand LIMS
Toxicology LIS
Technidata Functionality
LIMS for the Red Cross, FDA
FDA Contract
HIPAA 5010 Migration
Multi-Groups Capability
Metabolism LIMS
Middleware Platform
AJ Blomesystem LIMS
LabVantage Global Contract
Information Sharing
CHAPTER FIVE: MARKETS
Perspective
Managing the Data Tsunami
Replacement Market Opportunities
Laboratory Market Synopsis
Structure
Types Of Testing
Laboratory Types and Growth
Demographics Push Demand
Reimbursement
International Trends
Vendor Data
Mergers and Acquisitions
Market Place Impetus
The Clinical Laboratory Market
Market Forecasts
The Pharmaceutical Drug Discovery Lab Market
Market Forecasts
CHAPTER SIX: CORPORATE PROFILES
AAC Infotray AG
Abbott Starlims
Accelrys Inc
Accelerated Technology Laboratories Inc
AJ Blomesystem GmbH
ASM Soft SL
Autoscribe
Baytek International
Benetech Medical Systems
Blaze Systems
Caliber Infosolutions Inc
CambridgeSoft
Cerner Corp
ChemWare Inc
Clinical Software Solutions
Clinical Systems Ltd
Common Cents Systems
CompuGroup Medical
Core Informatics
Custom Software Ltd
Data Unlimited International Inc.
Desarrollo Aplicaciones Sanitarias SL
eBioSys Pty Ltd
Elekta AB
GenoLogics Life Sciences Software Inc
H&A Scientific Inc
Interface Engineering Co. Ltd.
Kriti Microsystems Pvt. Ltd
LabLogic Systems Ltd
LabVantage Solutions Inc
LabWare Inc
LIMS at Work GmbH
McKesson Technology Solutions
Modul-Bio
Multidata Computer Systems Inc.
NeTLIMS NJ LLC
NXG Group
Odysis SA
Orchard Software Corp
PathCentral
Polisystem Informatica Srl
Sapio Sciences LLC
SCC Soft Computer
Sciformatix
Siemens Healthcare
Software Point Oy
Swisslab GmbH
Tainosystems
Technidata
Thermo Fisher Scientific
Timeless Medical Systems
Two Fold Software Ltd
Visual Access Health Systems Pvt. Ltd
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Exhibit 1
Significant Trends in the Laboratory Information Market
Exhibit 2
World Market for Clinical Laboratory Automation Systems, 2013-2017
Exhibit 3
World Market for Drug Discovery Laboratory Information Systems, 2013-2017
CHAPTER TWO: INTRODUCTION
Exhibit 4
Selected Vendors of Enterprise-Capable LIS/LIMS
Exhibit 5
Laboratory Information Systems Selected Vendors, Interface Capabilities, 2012
CHAPTER THREE: TRENDS
Exhibit 6
Significant Trends in the Laboratory Information Systems Market
Exhibit 7
Key LIS Selection Issues
CHAPTER FIVE: MARKETS
Exhibit 8
Key Facts About Clinical Diagnostic Laboratories
Exhibit 9
Growth in Clinical Laboratories, 1997-2011
Exhibit 10
Laboratories by Type of Facility July 2012
Exhibit 11
Leading US Independent Laboratory Groups, 2011
Exhibit 12
Certificate of Compliance Laboratories By Certificate Schedule, July 2012
Exhibit 13
Major Pharmaceutical Companies Number of Potential Lab Sites for Laboratory
Information Systems. 2012
Exhibit 14
The US Population 1980-2020
Exhibit 15
Percent of US Population Over Age 65 by Year
Exhibit 16
The World Population 1980-2020
Exhibit 17
Average Life Expectancy in Years by Selected Country 1980, 2004 and 2011
Exhibit 18
Clinical Laboratory Clients and Payers by Type (%)
Exhibit 19
Laboratory Information Systems Selected Vendors with Hospital Contracts Number of Contracts, 2012
Exhibit 20
Laboratory Information Systems Selected Vendors Annual Number of Billed Tests, Average in A Range In Millions, 2012
Exhibit 21
Laboratory Information Systems Selected Vendors, Interface Capabilities 2012
Exhibit 22
Laboratory Information Systems Selected Vendors, Approximate Number of Contracts/Operating Sites 2012
Exhibit 23
Recent Key Mergers and Acquisitions
Exhibit 24
World Market for Clinical Lab Information Systems 2012-2017
Exhibit 25
World Market for Clinical Lab Information Systems 2012-2017 By Geographic Segment
Exhibit 26
World Market for Clinical Lab Information Systems Software, Hardware, Implementation Services by Percentage 2012-2017
Exhibit 27
North American Market for Clinical Lab Information Systems Software, Hardware, Implementation Services by Percentage 2012-2017
Exhibit 28
Brazilian Market for Clinical Lab Information Systems Software, Hardware, Implementation Services by Percentage 2012-2017
Exhibit 29
Japanese Market for Clinical Lab Information Systems Software, Hardware, Implementation Services by Percentage 2012-2017
Exhibit 30
European Market for Clinical Lab Information Systems Software, Hardware, Implementation Services by Percentage 2012-2017
Exhibit 31
Rest of World Market for Clinical Lab Information Systems Software, Hardware, Implementation Services by Percentage 2012-2017
Exhibit 32
World Market for Drug Discovery Lab Information Systems 2012-2017
Exhibit 33
World Market for Drug Discovery Lab Information Systems 2012-2017 By Geographic Segment
Exhibit 34
World Market for Drug Discovery Lab Information Systems Software, Hardware, Implementation Services by Percentage 2012-2017
Exhibit 35
North American Market for Drug Discovery Lab Information Systems Software, Hardware, Implementation Services by Percentage 2012-2017
Exhibit 36
Brazilian Market for Drug Discovery Lab Information Systems Software, Hardware, Implementation Services by Percentage 2012-2017
Exhibit 37
Japanese Market for Drug Discovery Lab Information Systems Software, Hardware, Implementation Services by Percentage 2012-2017
Exhibit 38
European Market for Drug Discovery Lab Information Systems Software, Hardware, Implementation Services by Percentage 2012-2017
Exhibit 39
Rest of World Market for Drug Discovery Lab Information Systems Software, Hardware, Implementation Services by Percentage 2012-2017
